248 related articles for article (PubMed ID: 27927214)
1. Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.
Kwon HW; Shin JH; Lim DH; Ok WJ; Nam GS; Kim MJ; Kwon HK; Noh JH; Lee JY; Kim HH; Kim JL; Park HJ
BMC Complement Altern Med; 2016 Dec; 16(1):508. PubMed ID: 27927214
[TBL] [Abstract][Full Text] [Related]
2. Immunostimulatory effects of cordycepin-enriched WIB-801CE from Cordyceps militaris in splenocytes and cyclophosphamide-induced immunosuppressed mice.
Shin JS; Chung SH; Lee WS; Lee JY; Kim JL; Lee KT
Phytother Res; 2018 Jan; 32(1):132-139. PubMed ID: 29168246
[TBL] [Abstract][Full Text] [Related]
3. Cordycepin-enriched WIB801C from Cordyceps militaris inhibits ADP-induced [Ca(2+)] i mobilization and fibrinogen binding via phosphorylation of IP 3R and VASP.
Lee DH; Kwon HW; Kim HH; Lim DH; Nam GS; Shin JH; Kim YY; Kim JL; Lee JJ; Kwon HK; Park HJ
Arch Pharm Res; 2015 Jan; 38(1):81-97. PubMed ID: 25001901
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.
Endale M; Lee WM; Kamruzzaman SM; Kim SD; Park JY; Park MH; Park TY; Park HJ; Cho JY; Rhee MH
Br J Pharmacol; 2012 Sep; 167(1):109-27. PubMed ID: 22471932
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin-enriched WIB-801C from Cordyceps militaris improves functional recovery by attenuating blood-spinal cord barrier disruption after spinal cord injury.
Lee JY; Choi HY; Baik HH; Ju BG; Kim WK; Yune TY
J Ethnopharmacol; 2017 May; 203():90-100. PubMed ID: 28363523
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Wang TM; Chan CP; Lin BR; Yeung SY; Yeh CY; Cheng RH; Jeng JH
PLoS One; 2014; 9(8):e104310. PubMed ID: 25122505
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Chan CP; Chou HY; Chang BE; Yeung SY; Wang TM; Jeng JH
Toxicol Appl Pharmacol; 2012 Sep; 263(3):287-95. PubMed ID: 22789837
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
[TBL] [Abstract][Full Text] [Related]
10. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner.
Cho HJ; Cho JY; Rhee MH; Park HJ
Eur J Pharmacol; 2007 Mar; 558(1-3):43-51. PubMed ID: 17229422
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen.
Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A
Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug.
Lee JJ; Jin YR; Yu JY; Munkhtsetseg T; Park ES; Lim Y; Kim TJ; Pyo MY; Hong JT; Yoo HS; Kim Y; Yun YP
Atherosclerosis; 2009 Oct; 206(2):375-82. PubMed ID: 19345949
[TBL] [Abstract][Full Text] [Related]
14. Cordycepin-Enriched WIB801C from Cordyceps militaris Inhibits Collagen-Induced [Ca(2+)]i Mobilization via cAMP-Dependent Phosphorylation of Inositol 1, 4, 5-Trisphosphate Receptor in Human Platelets.
Lee DH; Kim HH; Cho HJ; Yu YB; Kang HC; Kim JL; Lee JJ; Park HJ
Biomol Ther (Seoul); 2014 May; 22(3):223-31. PubMed ID: 25009703
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of JLX001 on cerebral ischemia through inhibiting platelet activation and thrombus formation in rats.
Yan YY; Ao LY; Zhou L; Li CY; Fang WR; Shen WY; Liang BW; Zhu X; Li YM
Biomed Pharmacother; 2018 Oct; 106():805-812. PubMed ID: 29990874
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Bulnesia sarmienti aqueous extract on agonist-induced platelet activation and thrombus formation involves mitogen-activated protein kinases.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim KS; Hong JH; Kwak YS; Yun BS; Rhee MH
J Ethnopharmacol; 2010 Aug; 130(3):614-20. PubMed ID: 20558266
[TBL] [Abstract][Full Text] [Related]
18. Morin hydrate inhibits platelet activation and clot retraction by regulating integrin α
Nam GS; Lee KS; Nam KS
Eur J Pharmacol; 2019 Dec; 865():172734. PubMed ID: 31614139
[TBL] [Abstract][Full Text] [Related]
19. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation induced by U46619, a TXA2 analogue.
Cho HJ; Cho JY; Rhee MH; Lim CR; Park HJ
J Pharm Pharmacol; 2006 Dec; 58(12):1677-82. PubMed ID: 17331333
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet mechanism of an herbal mixture prepared from the extracts of Phyllostachys pubescens leaves and Prunus mume fruits.
Son E; Kim SH; Yang WK; Kim DS; Cha J
BMC Complement Altern Med; 2017 Dec; 17(1):541. PubMed ID: 29258493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
